The trinity of COVID-19: immunity, inflammation and intervention

Cited by (1,002)

Items 801–900 of 1,002

1. Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools
   Ahmed Serag, Mohamed Hasan, Enas H. Tolba, Ahmed M. Abdelzaher, Ayman Abo Elmaaty · 2021 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
2. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
   Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, Shigenari Ishizuka, Eri Ishikawa, Daisuke Motooka, Yuki Ozaki, Nicolas Sax, Yuichi Maeda, Yasuhiro Kato et al. · 2021 · The Journal of Experimental Medicine
3. Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2
   Fuyu Duan, Liyan Guo, Liuliu Yang, Yuling Han, Abhimanyu Thakur, Benjamin E. Nilsson-Payant, Pengfei Wang, Zhao Zhang, Chui Yan Ma, Xiaoya Zhou et al. · 2020
4. Roadblocks and fast tracks: How RNA binding proteins affect the viral RNA journey in the cell
   Erika Girardi, Sébastien Pfeffer, Thomas F. Baumert, Karim Majzoub · 2020 · Seminars in Cell and Developmental Biology
5. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
   Jesús Porta-Etessam, Ivan Javier Nuñez-Gil, Nuria González García, Cristina Fernández, María Carmen Viana-Llamas, Charbel Maroun‐Eid, Rodolfo Romero, María Molina, Aitor Uribarri, Víctor Manuel Becerra‐Muñoz et al. · 2021 · Infection
6. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis
   Eugenio Hardy, Carlos Fernández-Patrón · 2021 · Biomolecules
7. Lung histopathological findings in COVID-19 disease – a systematic review
   Giuseppe Pannone, Vito Carlo Alberto Caponio, Ilenia Sara De Stefano, Maria Antonietta Ramunno, Mario Meccariello, Alessio Agostinone, Maria Carmela Pedicillo, Giuseppe Troiano, Khrystyna Zhurakivska, Tommaso Cassano et al. · 2021 · Infectious Agents and Cancer
8. Potential benefits of ginseng against COVID-19 by targeting inflammasomes
   Young‐Su Yi · 2022 · Journal of Ginseng Research
9. The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review
   Samya A. Omoush, Jihad A. M. Alzyoud · 2022 · Pathogens
10. Impact of nanoparticle properties on immune cell interactions in the lymph node
    Muhammad Asim Farooq, Angus P. R. Johnston, Natalie L. Trevaskis · 2024 · Acta Biomaterialia
11. Balancing Personal Privacy and Public Safety During COVID-19: The Case of South Korea
    Na Young Ahn, Jun Eun Park, Dong Hoon Lee, Paul C. Hong · 2020 · IEEE Access
12. Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation
    Acharya Balkrishna, Siva Kumar Solleti, Sudeep Verma, Anurag Varshney · 2020 · Molecules
13. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19
    Sümeyye Kazancıoğlu, Fatma Meriç Yılmaz, Aliye Baştuğ, Arzu Sakallı, Bahadır Orkun Özbay, Cansu Buyuktarakci, Hürrem Bodur, Gülşen Yılmaz · 2020 · Viral Immunology
14. Network Meta‐Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID‐19 Pathologies
    Wenfei Huang, Heping Zhou, Colin A. Hodgkinson, Angelo Montero, David A Goldman, Sulie L. Chang · 2021 · Alcoholism Clinical and Experimental Research
15. In silico Studies on the Interaction between Mpro and PLpro From SARS‐CoV‐2 and Ebselen, its Metabolites and Derivatives
    Pablo A. Nogara, Folorunsho Bright Omage, Gustavo Roni Bolzan, Cássia P. Delgado, Michael Aschner, Laura Orian, João Batista Teixeira da Rocha · 2021 · Molecular Informatics
16. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
    Min-Tser Liao, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, Mei‐Chen Lee, Wan‐Chung Hu, Kuo‐Wang Tsai, Chung‐Hsiang Yang, Chien‐Lin Lu, Sheng-Kang Chiu, Kuo‐Cheng Lu · 2021 · Antioxidants
17. Organoid and microfluidics-based platforms for drug screening in COVID-19
    Roya Ramezankhani, Roya Solhi, Yoke Chin Chai, Massoud Vosough, Catherine M. Verfaillie · 2021 · Drug Discovery Today
18. Effects of Vertical Transmission of Respiratory Viruses to the Offspring
    Sara Manti, Salvatore Leonardi, Fariba Rezaee, Terri J. Harford, Miriam K. Perez, Giovanni Piedimonte · 2022 · Frontiers in Immunology
19. Polarization of Microglia and Its Therapeutic Potential in Sepsis
    Léo Victor Grimaldi de Castro, Cassiano Felippe Gonçalves-de-Albuquerque, Adriana Ribeiro Silva · 2022 · International Journal of Molecular Sciences
20. Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19
    Elisa Brauns, Abdulkader Azouz, David Grimaldi, Hanxi Xiao, Séverine Thomas, Muriel Nguyen, Véronique Olislagers, Inès Vu Duc, Carmen Orte Cano, V. del Mármol et al. · 2022 · JCI Insight
21. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
    Kamal S. Saini, Carlo Lanza, Marco Romano, Evandro de Azambuja, Javier Cortés, Begoña de las Heras, Javier de Castro, Monika Lamba Saini, Sibylle Loibl, Giuseppe Curigliano et al. · 2020 · British Journal of Cancer
22. Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility
    Flavia Biamonte, Cirino Botta, Maria Mazzitelli, Salvatore Rotundo, Enrico Maria Trecarichi, DANIELA PATRIZIA FOTI, Carlo Torti, Giuseppe Viglietto, Daniele Torella, Francesco Saverio Costanzo · 2021 · Journal of Translational Medicine
23. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
    Z. Khoshkam, Y. Aftabi, P. Stenvinkel, B. P. Lawrence, M. Rezaei, G. Ichihara, S. Fereidouni · 2021 · Journal of Advanced Research
24. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
    Alfredo Mendrone, Carla Luana Dinardo, Suzete C. Ferreira, Anna Shoko Nishiya, Nanci A. Salles, Cesar de Almeida‐Neto, Débora Toshie Hamasaki, Tila Facincani, Lucas Bassolli de Oliveira Alves, Rafael Rahal Guaragna Machado et al. · 2021 · Transfusion
25. Early and Significant Reduction in C‐Reactive Protein Levels After Corticosteroid Therapy Is Associated With Reduced Mortality in Patients With COVID‐19
    Zhu Cui, Zachary Merritt, Andrei Assa, Hashim Mustehsan, Erica Chung, Sichen Liu, Anand Ajit Kumthekar, Bibi Ayesha, Margaret McCort, Leonidas Palaiodimos et al. · 2021 · Journal of Hospital Medicine
26. Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario
    Roberto Tonelli, Alessandro Marchioni, Luca Tabbì, Riccardo Fantini, Stefano Busani, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi et al. · 2021 · Journal of Clinical Medicine
27. Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review
    Sarah F. Alsobaie · 2021 · Infection and Drug Resistance
28. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies
    Yue Shen, Cheng Cheng, Xue Yan Zheng, Yuefei Jin, Guangcai Duan, Mengshi Chen, Shuaiyin Chen · 2021 · Medicina
29. Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
    Serena Marchi, Simonetta Viviani, Edmond J. Remarque, Antonella Ruello, Emilio Bombardieri, Valentina Bollati, Gregorio Paolo Milani, Alessandro Manenti, Giulia Lapini, Annunziata Rebuffat et al. · 2021 · PLoS ONE
30. Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
    Weihang He, Xiaoqiang Liu, Bing Hu, Dongshui Li, Luyao Chen, Yu Li, Yechao Tu, Situ Xiong, Gongxian Wang, Jun Deng et al. · 2022 · Frontiers in Cellular and Infection Microbiology
31. Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review
    Christo Kole, Εleni Stefanou, Nikolaos Karvelas, Dimitriοs Schizas, Konstantinos P. Toutouzas · 2023 · Cardiovascular Drugs and Therapy
32. Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients
    Laura Ochoa‐Callejero, Josune Garcı́a-Sanmartı́n, Pablo Villoslada-Blanco, María Íñiguez, Patricia Pérez‐Matute, Elisabet Pujadas, Mary Elizabeth Fowkes, Rachel Brody, José Antonio Oteo, Alfredo Martı́nez · 2021 · Journal of the Endocrine Society
33. In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches
    Alonso Vivar-Sierra, María José Araiza-Macías, José Patricio Hernández Contreras, Arely Vergara‐Castañeda, Gabriela Ramírez-Vélez, Rodolfo Pinto‐Almazán, Juan Rodrigo Salazar, Marco A. Loza-Mejía · 2021 · Molecules
34. The Nexus Between Telomere Length and Lymphocyte Count in Seniors Hospitalized With COVID-19
    Athanase Bénétos, Tsung‐Po Lai, Simon Toupance, Carlos Labat, Simon Verhulst, Sylvie Gautier, Marie‐Noëlle Ungeheuer, Christine Perret‐Guillaume, Daniel A Levy, Ezra Susser et al. · 2021 · The Journals of Gerontology Series A
35. Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics
    Ajita Jindal, Sounik Sarkar, Aftab Alam · 2021 · Frontiers in Chemistry
36. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies
    Kalliopi K. Gkouskou, Theodora Vasilogiannakopoulou, Evangelos Andreakos, Nikolaos Davanos, Maria Gazouli, Despina Sanoudou, Aristides G. Eliopoulos · 2021 · Redox Biology
37. The in-vitro effect of famotidine on SARS-CoV-2 proteases and virus replication
    Madeline K. Loffredo, Héctor A. Lucero, D. W. Chen, Aoife Kateri O’Connell, Simon Bergqvist, Ahmad Munawar, Asanga Bandara, Steff De Graef, S.D. Weeks, Florian Douam et al. · 2021 · Scientific Reports
38. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2
    Mohammad Ali Derakhshan, Amir Amani, Reza Faridi Majidi · 2021 · ACS Applied Materials & Interfaces
39. Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
    Carmela Conte · 2021 · International Journal of Molecular Sciences
40. Long-chain polyphosphates impair SARS-CoV-2 infection and replication
    Veronica Ferrucci, Dae-Young Kong, Fatemeh Asadzadeh, Laura Marrone, Angelo Sabato Boccia, Roberto Siciliano, Giuseppina Criscuolo, Camilla Anastasio, Fabrizio Quarantelli, Marika Comegna et al. · 2021 · Science Signaling
41. How dendritic cells sense and respond to viral infections
    Laura Marongiu, Mihai Valache, Fabio Alessandro Facchini, Francesca Granucci · 2021 · Clinical Science
42. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
    Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, Grazia Graziani · 2020 · Biochemical Pharmacology
43. Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells
    Richard Schäfer, Gabriele Spohn, Marco Bechtel, Denisa Bojková, Patrick C. Baer, Selim Kuçi, Erhard Seifried, Sandra Ciesek, Jindrich Jr. Cinatl · 2020 · Stem Cell Reports
44. Bio-inspired Ag nanovilli-based sandwich-type SERS aptasensor for ultrasensitive and selective detection of 25-hydroxy vitamin D3
    Woochang Kim, Joohyung Park, Woong Kim, Seongjae Jo, Minwoo Kim, Chihyun Kim, Hyunjun Park, Doyeon Bang, Wonseok Lee, Jinsung Park · 2021 · Biosensors and Bioelectronics
45. Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C
    Peter D. Burbelo, Riccardo Castagnoli, Chisato Shimizu, Ottavia M. Delmonte, Kerry Dobbs, Valentina Discepolo, Andrea Lo Vecchio, Alfredo Guarino, Francesco Licciardi, Ugo Ramenghi et al. · 2022 · Frontiers in Immunology
46. COVID-19 disease and autoimmune disorders: A mutual pathway
    Mohammed Al‐Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy · 2022 · World Journal of Methodology
47. COVID-19: Diabetes Perspective—Pathophysiology and Management
    Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, Ramya Ramachandra, SubbaRao V. Madhunapantula, Ravindra P. Veeranna · 2023 · Pathogens
48. Harnessing Memory NK Cell to Protect Against COVID-19
    Saeede Soleimanian, Ramin Yaghobi · 2020 · Frontiers in Pharmacology
49. Commonalities Between COVID-19 and Radiation Injury
    Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo · 2020 · Radiation Research
50. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
    Georgina M. Ellison, Liam Sean Colley, Katie A. O’Brien, Kirsty A. Roberts, Thomas A. Agbaedeng, Mark Ross · 2020 · Frontiers in Cardiovascular Medicine
51. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients
    Anguraj Sadanandam, Tobias Bopp, Santosh Dixit, David J. H. F. Knapp, Chitra Priya Emperumal, Paschalis I. Vergidis, Krishnaraj Rajalingam, Alan A. Melcher, Nagarajan Kannan · 2020 · Cell Death Discovery
52. COVID-19 Pandemic
    Pouran D. Faghri, Marnie Dobson, Paul A. Landsbergis, Peter L. Schnall · 2021 · Journal of Occupational and Environmental Medicine
53. Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network
    Claire Dupuis, Étienne de Montmollin, Niccolò Buetti, Dany Goldgran-Tolédano, Jean Reignier, Carole Schwebel, Julien Domitile, Mathilde Neuville, Moreno Ursino, Shidasp Siami et al. · 2021 · PLoS ONE
54. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study
    David Saadoun, Matheus Vieira, Mathieu Vautier, Xenofon Baraliakos, Ioana Andreica, José António Pereira da Silva, Marlene Sousa, Mariana Luís, Nikita Khmelinskii, J. M. Alvaro Gracia et al. · 2021 · The Lancet Rheumatology
55. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells
    Bianca Maria Rotoli, Amelia Barilli, Rossana Visigalli, Francesca Ferrari, Valeria Dall’Asta · 2021 · Biomedicines
56. Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study
    Alejandro Durán-Méndez, Alma Delia Aguilar-Arroyo, Emiliano Vivanco-Gómez, Eduardo Nieto-Ortega, Daniela Pérez-Ortega, Cristian Jiménez-Pérez, Karla Y. Hernández-Skewes, Guillermo Montiel-Bravo, Oscar J. Roque-Reyes, Fernanda Romero-Lechuga et al. · 2021 · Scientific Reports
57. Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response
    Lu Zhao, Hao Liu, Yingchao Wang, Shufang Wang, Dejin Xun, Yi Wang, Yiyu Cheng, Boli Zhang · 2021 · Engineering
58. Characteristics of pregnant patients with COVID-19 and liver injury
    Guangtong Deng, Furong Zeng, Lijuan Zhang, Hui Chen, Xiang Chen, Mingzhu Yin · 2020 · Journal of Hepatology
59. Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells
    Benjamin J. Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena Chee, Anthony Kusnadi, Hayley A. Simon, Alba Grifoni, Emanuela Pelosi, Daniela Weiskopf, Alessandro Sette et al. · 2020 · SSRN Electronic Journal
60. Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection
    Sameh S. M. Soliman, MoezAlIslam E. Faris, Zakaria Ratemi, Rabih Halwani · 2020 · Annals of Nutrition and Metabolism
61. Stromal–immune cell crosstalk fundamentally alters the lung microenvironment following tissue insult
    Julie C. Worrell, Megan K. L. MacLeod · 2021 · Immunology
62. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
    Gino M Dettorre, Saoirse Olivia Dolly, Angela Loizidou, John David Chester, Amanda M. Jackson, Uma Mukherjee, Alberto Zambelli, Mark Bower, Christopher C.T. Sng, Ramón Salazar et al. · 2021 · Journal for ImmunoTherapy of Cancer
63. Safety and Efficacy of the Common Vaccines against COVID-19
    Ying Liu, Qing Ye · 2022 · Vaccines
64. Altered Serum Uric Acid Levels in Kidney Disorders
    Gheun‐Ho Kim, Jae‐Bum Jun · 2022 · Life
65. Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
    Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, Wei Guo Qian, Ruixuan Zhang, In Su Cheon, Yue Wu, Chaofan Li, Russell G. Jones, Mark H. Kaplan et al. · 2023 · Science Immunology
66. ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic
    Miguel Ángel Loyola-Cruz, Luis Uriel Gonzalez-Avila, Arturo Martínez-Trejo, Andrés Saldaña-Padilla, Cecilia Hernández‐Cortez, Juan Manuel Bello–López, Graciela Castro‐Escarpulli · 2023 · Pathogens
67. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review
    Marzena Wyganowska‐Świątkowska, Michal Nohawica, Katarzyna Grocholewicz, Gerard Nowak · 2020 · International Journal of Molecular Sciences
68. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection
    Anandita Pal, Kymberly M. Gowdy, Kenneth J. Oestreich, Melinda A. Beck, Saame Raza Shaikh · 2020 · Frontiers in Immunology
69. How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so far
    Sumana Sanyal · 2020 · Emerging Topics in Life Sciences
70. SARS‐CoV‐2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID‐19 severity and mortality
    Pierrick Le Borgne, Morgane Solis, François Séverac, Hamid Merdji, Yvon Ruch, Karine Alamé, Éric Bayle, Yves Hansmann, Pascal Bilbault, Samira Fafi‐Kremer et al. · 2021 · Academic Emergency Medicine
71. Advances in vaccine delivery systems against viral infectious diseases
    Dongyoon Kim, Yina Wu, Young Bong Kim, Yu‐Kyoung Oh · 2021 · Drug Delivery and Translational Research
72. COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
    Mohapradeep Mohan, Benjamin Ian Perry, Ponnusamy Saravanan, Swaran Preet Singh · 2021 · Frontiers in Psychiatry
73. The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
    Alessio Danilo Inchingolo, Gianna Dipalma, Angelo Michele Inchingolo, Giuseppina Malcangi, Luigì Santacroce, Maria Teresa D’Oria, Ciro Gargiulo Isacco, Ioana Roxana Bordea, Sebastian Candrea, Antônio Scarano et al. · 2021 · Antioxidants
74. SARS-CoV-2, BACTERIAL CO-INFECTIONS, AND AMR: THE DEADLY TRIO IN COVID-19?
    José Antonio Bengoechea, Connor Bamford · 2020 · Juvenis scientia
75. Platelet extracellular vesicles in COVID-19: Potential markers and makers
    Florian Puhm, Louis Flamand, Éric Boilard · 2021 · Journal of Leukocyte Biology
76. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
    Hao Zhang, Bo Shao, Qin Dang, Zhuang Chen, Quanbo Zhou, Hong Luo, Weitang Yuan, Zhenqiang Sun · 2021 · Frontiers in Immunology
77. Pulmonary surfactant as a versatile biomaterial to fight COVID-19
    Lore Herman, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Journal of Controlled Release
78. Biomarkers of ageing and frailty may predict COVID-19 severity
    Kailyn J. Wanhella, Carlos Fernández-Patrón · 2021 · Ageing Research Reviews
79. Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
    Tøri Vigeland Lerum, Niklas Maltzahn, Pål Aukrust, Marius Trøseid, Katerina Nezvalova Henriksen, Trine Kåsine, Anne Ma Dyrhol‐Riise, Birgitte Stiksrud, Mette Haugli, Bjørn Blomberg et al. · 2021 · Scientific Reports
80. SARS‐CoV‐2 triggered oxidative stress and abnormal energy metabolism in gut microbiota
    Tuoyu Zhou, Jingyuan Wu, Yufei Zeng, Junfeng Li, Jun Yan, Wenbo Meng, Huawen Han, Fengya Feng, Jufang He, Shuai Zhao et al. · 2022 · MedComm
81. Kynurenine pathway in Coronavirus disease (COVID‐19): Potential role in prognosis
    Murat Cihan, Özlem Doğan, Ceyhan Ceran Serdar, Arzu Altunçekiç Yıldırım, Celali Kurt, Muhittin Abdulkadir Serdar · 2022 · Journal of Clinical Laboratory Analysis
82. Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
    Christina Brennan, Sandeep Nadella, Xiang Zhao, Richard J. Dima, Nicole Jordan–Martin, Breanna R. Demestichas, Sam O. Kleeman, Miriam Ferrer, Eva Gablenz, Nicholas Mourikis et al. · 2022 · Gut
83. Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
    Yan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, Camille Carmona, Yang Zhou, Derek Pok Him Lee, Jiaji Yu, Jie Huang, Jocelyn T. Kim, Vaithilingaraja Arumugaswami et al. · 2022 · Stem Cell Research & Therapy
84. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
    Tobias W. Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, Oltin T. Pop, Ann-Kristin Jochum, Lorenz Risch, Silvio D. Brugger, Ana Velić, David Bomze, Philipp P. Kohler et al. · 2022 · American Journal of Respiratory and Critical Care Medicine
85. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management
    Amit Verma, Amitava Adhikary, Gayle E. Woloschak, Bilikere Srinivasa Rao Dwarakanath, Rao V. L. Papineni · 2020 · International Journal of Radiation Biology
86. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment
    Felipe Saldanha‐Araújo, Emañuella Melgaço Garcez, Amandda Évelin Silva-Carvalho, Juliana Lott Carvalho · 2020 · Frontiers in Immunology
87. Immunotherapy for SARS-CoV-2: potential opportunities
    Mehrnoosh Pashaei, Nima Rezaei · 2020 · Expert Opinion on Biological Therapy
88. Multivalent nanomedicines to treat COVID-19: A slow train coming
    Tanveer Ahmad Tabish, Michael Richard Hamblin · 2020 · Nano Today
89. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19
    Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, Jinguo Ye, Wen Wen, Hao Tang, Wenru Su et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
90. The rapid adaptation of SARS-CoV-2–rise of the variants: transmission and resistance
    Sandrine Mabekou Soh, Yeongjun Kim, Chanwoo Kim, Ui Soon Jang, Hye-Ra Lee · 2021 · The Journal of Microbiology
91. Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews
    Federica Di Spirito, Alfredo Iandolo, Alessandra Amato, Mario Caggiano, Annunziata Raimondo, Serena Lembo, Stefano Martina · 2022 · International Journal of Environmental Research and Public Health
92. Colostrum ingredients, its nutritional and health benefits - an overview
    Mohamed Mansour El-Loly · 2022 · Clinical Nutrition Open Science
93. The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies
    Giuseppe Miceli, Maria Grazia Basso, Giuliana Rizzo, Chiara Pintus, Antonino Tuttolomondo · 2022 · International Journal of Molecular Sciences
94. Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
    Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi · 2023 · Future Virology
95. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications
    Subramanian Loganathan, Sandeep N. Athalye, Shashank Joshi · 2020 · Expert Opinion on Biological Therapy
96. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
    Luís Henrique Angenendt da Costa, Bruna M. Santos, Luiz G.S. Branco · 2020 · European Journal of Pharmacology
97. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients
    Léonie A. N. Staats, Hella Pfeiffer, Jasmin Knopf, Aylin Lindemann, Julia Fürst, Andreas Emanuel Kremer, Holger Hackstein, Markus Friedrich Neurath, Luis Enrique Munoz, Susanne Achenbach et al. · 2020 · Cells
98. Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature
    Ariel Munitz, Liat Edry‐Botzer, Michal Itan, Ran Tur‐Kaspa, Dror Dicker, Dana Marcoviciu, Moran G. Goren, Michael Mor, Shir Lev, Tamar Gottesman et al. · 2021 · Scientific Reports
99. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan
    Takuya Hara, Kenji Furuno, Kenichiro Yamamura, Junji Kishimoto, Yumi Mizuno, Kenji Murata, Sagano Onoyama, Ken Hatae, Megumi Takemoto, Yoshito Ishizaki et al. · 2021 · JAMA Network Open
100. SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
     Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antônio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco et al. · 2021 · Microorganisms